Abstract:Colorectal cancer (CRC) is one of the most common cancers worldwide. As with other cancers, CRC is a multifactorial disease due to the combined effect of genetic and environmental factors. Most cases are sporadic, but a small proportion is hereditary, estimated at around 5-10%. In both, the tumor interacts with heterogeneous cell populations, such as endothelial, stromal, and immune cells, secreting different signals (cytokines, chemokines or growth factors) to generate a favorable tumor microenvironment for cancer cell invasion and metastasis. There is ample evidence that inflammatory processes have a role in carcinogenesis and tumor progression in CCR. Different profiles of cell activation of the tumor microenvironment can promote pro or anti-tumor pathways; hence they are studied as a key target for the control of cancer progression. Additionally, the intestinal mucosa is in close contact with a microorganism community, including bacteria, bacteriophages, viruses, archaea, and fungi composing the gut microbiota. Aberrant composition of this microbiota, together with alteration in the diet‐derived microbial metabolites content (such as butyrate and polyamines) and environmental compounds has been related to CRC. Some bacteria, such as pks+ Escherichia coli or Fusobacterium nucleatum , are involved in colorectal carcinogenesis through different pathomechanisms including the induction of genetic mutations in epithelial cells and modulation of tumor microenvironment. Epithelial and immune cells from intestinal mucosa have Pattern-recognition receptors and G-protein coupled receptors (receptor of butyrate), suggesting that their activation can be regulated by intestinal microbiota and metabolites. In this review, we discuss how dynamics in the gut microbiota, their metabolites, and tumor microenvironment interplays in sporadic and hereditary CRC, modulating tumor progression.

Genetics, diet, microbiota, and metabolome: partners in crime for colon carcinogenesis

The Pivotal Role of the Gut Microbiome in Colorectal Cancer

Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment

How Gut Microbiota May Influence Colorectal Cancer Metastatic Potential

Gut microbiota drives colon cancer risk associated with diet: a comparative analysis of meat-based and pesco-vegetarian diets

Colorectal Cancer and Microbiota Modulation for Clinical Use. A Systematic Review

Microbiota-Associated Metabolites and Related Immunoregulation in Colorectal Cancer

Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer

Microbiota and beneficial metabolites in colorectal cancer

Functional links between the microbiome and the molecular pathways of colorectal carcinogenesis

Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer

Diet, Gut Microbiota, and Colorectal Cancer Prevention: a Review of Potential Mechanisms and Promising Targets for Future Research

Gut microbiota in inflammation and colorectal cancer: A potential Toolbox for Clinicians

Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges

Microbiota and other detrimental metabolites in colorectal cancer

The gut microbiota, bacterial metabolites and colorectal cancer

On the road to colorectal cancer development: crosstalk between the gut microbiota, metabolic reprogramming and epigenetic modifications.

Microbiome-driven carcinogenesis in colorectal cancer: Models and mechanisms

Gut microbiota and their derivatives in the progression of colorectal cancer: Mechanisms of action, genome and epigenome contributions

Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence

Exploring the Relationship Between Diet, Lifestyle and Gut Microbiome in Colorectal Cancer Development: A Recent Update